Clinical Trials
106 trialsFollow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
National Institutes of Health Clinical Center (CC)
Collection of Blood From Patients With Cancer
National Institutes of Health Clinical Center (CC)
A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors
EtiraRx Australia Pty Ltd
DISRUPT
Icahn School of Medicine at Mount Sinai
LEARN
University of Sydney
OvAR-Y
Washington University School of Medicine
The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
New Phase Ltd.
Brodalumab in the Treatment of Immune-Related Adverse Events
Columbia University
QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers.
NantBioScience, Inc.
Evaluation of Novel Cone-Beam CT for Guidance and Adaptation of Precision Radiotherapy
Varian, a Siemens Healthineers Company
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
ModeX Therapeutics, An OPKO Health Company
iCaRe2
University of Nebraska
CER
Cancer Support Community, Research and Training Institute, Philadelphia
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Exscientia AI Limited
Large Language Models Assist in Tumor MDT
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Feasibility Study of CBCT for IGRT in Cancer Patients
Varian, a Siemens Healthineers Company
MOMENTUM
UMC Utrecht
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
University of California, Irvine
ONE TEAM
Duke University
ESCAT
University Hospital, Lille
SELECT-CAR-NK
Essen Biotech
EBNK-ST-001
Essen Biotech
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Angiex, Inc.
A Study of SH009 Injection in Patients With Advanced Solid Tumors.
Nanjing Sanhome Pharmaceutical, Co., Ltd.
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
DualityBio Inc.
A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
PTC-IMPACT
Gene Solutions
SCORE
Natera, Inc.
SL-28 for Advanced Solid Tumours
Second Life Therapeutics
ELEPHAS-05
Elephas
Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging
UNC Lineberger Comprehensive Cancer Center
Immune Cell Therapy for Advanced Solid Tumors
Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
AYAConnect
UNC Lineberger Comprehensive Cancer Center
EARN
Washington University School of Medicine
Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2
Milton S. Hershey Medical Center
Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies
Novita Pharmaceuticals, Inc.
K-ACCELERATE
Gene Solutions
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
University of California, Irvine
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancers
Tvardi Therapeutics, Incorporated
A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver Metastases
Ruijin Hospital
IT-01
Intensity Therapeutics, Inc.
INSPIRE
Singlera Genomics Inc.
FUTURE
Assistance Publique Hopitaux De Marseille
Proteomic Analysis of Patients Undergoing Bariatric Surgery
Universidade Federal de Pernambuco
ROOT
Taproot Health
AI-Assisted Non-Contrast CT for Multi-Cancer Screening
Changhai Hospital
SPIRIT
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Measuring and Improving the Safety of Test Result Follow-Up
VA Office of Research and Development